Ocutheia
1 known investors
Ocutheia is a therapeutics developer creating treatments for age-related macular degeneration by targeting metabolic dysfunction in photoreceptors. Its approach addresses a molecular target upstream of validated mechanisms, with potential applications in the retina and beyond the eye.
BiotechDeep TechHealthtech